Aethlon Medical stockholders approve increase in authorized shares to 100M and equity plan amendment

AETHLON MEDICAL INC

Stockholders approved increase in authorized common shares from 6M to 100M (495,950 for, 58,624 against).
Stockholders approved 2020 Equity Incentive Plan amendment adding 100,000 shares (291,835 for, 18,607 against).
Five directors elected; Haskell & White LLP ratified as auditor for FY ending March 31, 2026.
Approved issuance of up to 1.66M shares upon warrant exercise and ~368k shares upon warrant inducement (Dec 2025 agreements).
All proposals passed; quorum of ~57% of outstanding shares represented.

item 5.02 item 5.07 item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

AETHLON MEDICAL INC: Increased authorized shares of common stock from 6,000,000 to 100,000,000 (effective 2026-02-19).

Change: charter amendment
Effective: 2026-02-19

Exact text from the filing

Our Board previously approved the amendment of our Articles of Incorporation, as amended, to increase the number of authorized shares of our common stock, par value $0.001 per share, from 6,000,000 shares to 100,000,000 shares (the “Articles Amendment”). As reported in Item 5.07 below, on February 19, 2026, our stockholders approved the Articles Amendment. The Articles Amendment was filed with the Secretary of State of the State of Nevada on February 19, 2026.

View on SEC.gov

40 governance changes filed in the last 30 days. Browse all governance changes →

AETHLON MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001683168-26-001259

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.